Kenvue Inc. Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $48.46 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 2.1× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Vanguard Sht-Term Inflation-Protected Sec Idx ETF pays none. Which is the better fit depends on your goals.
| KVUE | VTIP | |
|---|---|---|
Market Cap | $34.06B | $73.20B |
Volume | 23,267,228 | 2,511,360 |
Sector | Consumer Staples | — |
52-Week High | $19.83 | $50.46 |
52-Week Low | $14.11 | $48.38 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 91 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $48.49, up slightly by 0.06% today. The technical outlook is mixed, with a bearish trend from moving averages but bullish signals from oscillators like the RSI. Recent news highlights its role as an inflation hedge amid rising energy prices and Fed policy shifts, with institutional investors increasing positions. Key support sits at $48, with resistance at $49.
The outlook for VTIP is cautiously positive, offering a low-risk inflation hedge with minimal interest-rate sensitivity. Opportunities include protection against persistent inflation and real yield advantages, but risks involve Fed policy uncertainty and potential underperformance if inflation subsides. Investors should weigh its defensive role in a diversified portfolio.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →